Stock market listed pharmaceutical services firm hVIVO has signed a £13.1m (€15.2m) contract with a large global pharmaceutical company to develop an influenza B virus challenge model. Irish founded hVIVO,

Hvivo, the pharmaceutical services company formerly known as Open Orphan, has reported a jump in trading revenues in the first half of the year compared with the same period last

In Mo Khan’s words human metapneumovirus (hMPV) is a nasty virus and one that hopefully his company hVIVO will, by the end of 2024, have harnessed enough data about to allow its client to

Tom Scott, the popular YouTuber with 6 million subscribers, recently paid a visit to FluCamp’s facilities in Whitechapel, East London. In an exclusive video interview, Tom delves into the captivating

t is important to be register with a GP in the UK as they will be usually your first contact if you have a health problem, if you need to

Some people worry that clinical trials are not safe, however they have rules and regulations in place to protect the volunteers and make sure the trials are conducted properly. The

hVIVO plc (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge